Eli Lilly LLY Total Non-Current Liabilities
Total Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesNoncurrent.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's total non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's total non-current liabilities?
- Eli Lilly (LLY) reported total non-current liabilities of $48.74B in Q1 2026.
- How has Eli Lilly's total non-current liabilities changed year-over-year?
- Eli Lilly's total non-current liabilities increased by 12.1% year-over-year, from $43.47B to $48.74B.
- What is the long-term trend for Eli Lilly's total non-current liabilities?
- Over 5 years (2020 to 2025), Eli Lilly's total non-current liabilities has grown at a 12.4% compound annual growth rate (CAGR), from $28.33B to $50.71B.
- What does total non-current liabilities mean?
- The sum of all long-term obligations due beyond one year — long-term debt, lease liabilities, pension obligations, and deferred items.